ebomi
Colour theme
Sign in
Insider · CIK 0001633313

Avoro Capital Advisors LLC

CIK 0001633313 Name as filed on the most recent filing

Filed as Avoro Capital Advisors LLC (8)· venBio Select Advisor LLC (7)

27 transaction lines · from 15 filings · filed 2017-11-16 to 2026-07-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-07-28 Scribe Therapeutics, Inc.
SCTX 		P, Open-market purchase 7,905 acquired 18.25 144,266.25 Form 4, filing 0000902664-26-003270
2026-07-24 Scribe Therapeutics, Inc.
SCTX 		P, Open-market purchase 2,333,333 acquired 15.00 34,999,995.00 Form 4, filing 0000902664-26-003270
2026-07-24 Scribe Therapeutics, Inc.
SCTX 		P, Open-market purchase 50,000 acquired 22.31 1,115,500.00 Form 4, filing 0000902664-26-003270
2020-05-01 Immunomedics Inc
IMMU 		P, Open-market purchase 1,750,000 acquired 28.50 49,875,000.00 Form 4, filing 0000902664-20-001946
2019-12-05 Immunomedics Inc
IMMU 		P, Open-market purchase 2,000,000 acquired 17.50 35,000,000.00 Form 4, filing 0000902664-19-004538
2019-10-03 Immunomedics Inc
IMMU 		P, Open-market purchase 500,000 acquired 14.10 7,050,000.00 Form 4, filing 0000902664-19-003903
2019-10-02 Immunomedics Inc
IMMU 		P, Open-market purchase 1,000,000 acquired 13.23 13,230,000.00 Form 4, filing 0000902664-19-003903
2019-07-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 62,500 disposed 101.88 6,367,500.00 Form 4, filing 0000902664-19-003156
2019-06-28 Immunomedics Inc
IMMU 		P, Open-market purchase 250,000 acquired 13.84 3,460,000.00 Form 4, filing 0000902664-19-002892
2019-06-27 Immunomedics Inc
IMMU 		P, Open-market purchase 350,000 acquired 13.68 4,788,000.00 Form 4, filing 0000902664-19-002892
2019-06-26 Immunomedics Inc
IMMU 		P, Open-market purchase 400,000 acquired 13.25 5,300,000.00 Form 4, filing 0000902664-19-002892
2019-06-05 Immunomedics Inc
IMMU 		P, Open-market purchase 250,000 acquired 12.47 3,117,500.00 Form 4, filing 0000902664-19-002619
2019-06-04 Immunomedics Inc
IMMU 		P, Open-market purchase 500,000 acquired 12.10 6,050,000.00 Form 4, filing 0000902664-19-002619
2019-06-03 Immunomedics Inc
IMMU 		P, Open-market purchase 785,539 acquired 12.19 9,575,720.41 Form 4, filing 0000902664-19-002619
2019-05-15 Immunomedics Inc
IMMU 		P, Open-market purchase 125,000 acquired 14.95 1,868,750.00 Form 4, filing 0000902664-19-002373
2019-05-14 Immunomedics Inc
IMMU 		P, Open-market purchase 125,000 acquired 15.40 1,925,000.00 Form 4, filing 0000902664-19-002373
2019-05-13 Immunomedics Inc
IMMU 		P, Open-market purchase 500,000 acquired 15.07 7,535,000.00 Form 4, filing 0000902664-19-002373
2019-03-20 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 23,781 disposed 72.80 1,731,256.80 Form 4, filing 0000902664-19-001604
2019-03-19 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 100,000 disposed 73.43 7,343,000.00 Form 4, filing 0000902664-19-001604
2019-03-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 125,000 disposed 76.55 9,568,750.00 Form 4, filing 0000902664-19-001604
2019-02-20 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 686,820 disposed 73.00 50,137,860.00 Form 4, filing 0000902664-19-001248
2018-06-15 Immunomedics Inc
IMMU 		P, Open-market purchase 200,000 acquired 23.39 4,678,000.00 Form 4, filing 0000902664-18-002624
2018-06-15 Immunomedics Inc
IMMU 		P, Open-market purchase 575,000 acquired 24.00 13,800,000.00 Form 4, filing 0000902664-18-002593
2018-06-11 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 400,000 acquired 38.85 15,540,000.00 Form 4, filing 0000902664-18-002549
2017-11-16 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 650,000 acquired 13.00 8,450,000.00 Form 4, filing 0000902664-17-004377
2017-11-15 Immunomedics Inc
IMMU 		P, Open-market purchase 175,000 acquired 10.97 1,919,750.00 Form 4, filing 0000902664-17-004371
2017-11-14 Immunomedics Inc
IMMU 		P, Open-market purchase 1,150,000 acquired 10.39 11,948,500.00 Form 4, filing 0000902664-17-004371

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Avoro Capital Advisors LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001633313

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.